Kiora Pharmaceuticals Gross Profit

Kiora Pharmaceuticals (KPRX) currently reports a gross profit of $-11K as of June 2026. That compares with $-16M in the prior-year period — up 99.9% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Kiora Pharmaceuticals's gross profit history and peer comparisons.

Kiora Pharmaceuticals's gross profit increased from $-16M to $-11K — a 99.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiora Pharmaceuticals's gross profit of $-11K is lower than the Healthcare sector average of $65B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Kiora Pharmaceuticals reported $-11K in gross profit as of June 2026. That compares with $-16M in the prior-year period — up 99.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-11K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Kiora Pharmaceuticals, and consider following KPRX for alerts when major investors trade the stock.